High dose exposure to anticholinesterases which results in symptomatic pois
oning can have lasting consequences due to the trauma of intoxication, exci
totoxicity, secondary hypoxic damage, and (for some agents) a delayed onset
polyneuropathy (OPIDN). The potential effects of low level exposure are le
ss well defined. The most reliable data comes from controlled clinical tria
ls with specific agents. A single dose of sarin or repeated doses of metrif
onate or mevinphos, have produced only transient adverse effects at doses c
ausing substantial acetylcholinesterase inhibition. Other data comes from e
pidemiological surveys. These have often used more sensitive indices than t
he clinical studies, but are less reliable due to the difficulty of definin
g exposure and matching control and exposed populations. Subtle, mainly cog
nitive, differences between exposed and non-exposed populations are sometim
es seen. Low level exposure can cause a reversible down-regulation of choli
nergic systems, and a range of non-cholinesterase effects that are structur
e-specific, and do not always parallel acute toxicity. Novel protein target
s sensitive to low level exposure to some organophosphates are known to exi
st in the brain, but their functional significance is not yet understood. (
C) 1998 Elsevier Science Ireland Ltd. All rights reserved.